Skip to content
UM-SCC-129
Tissue
Head and neck
Disease
Head and neck squamous cell carcinoma (HNSCC)
Metastatic site
Primary tumor site (head and neck)

Documents

UM-SCC-129

Cell line · Product number 305727

UM-SCC-129 is a human head and neck squamous cell carcinoma (HNSCC) cell line established from a patient tumor at the University of Michigan Head and Neck...

US$777.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

UM-SCC-129 is a human head and neck squamous cell carcinoma (HNSCC) cell line established from a patient tumor at the University of Michigan Head and Neck Oncology Laboratory. As part of the UM-SCC cell line panel — one of the most extensively characterized and widely distributed HNSCC cell line collections in the world — UM-SCC-129 provides a defined in vitro model for head and neck squamous cell carcinoma research. The UM-SCC series was developed over 40+ years from over 100 patient donors at the University of Michigan and is distinguished by well-documented STR profiles, TP53 mutation status, and radiation sensitivity data across the collection.

UM-SCC-129 is applicable in HNSCC biology research, radiation sensitivity studies, chemotherapy sensitivity testing (cisplatin, 5-FU, cetuximab), EGFR pathway analysis, TP53 functional studies, and evaluation of novel targeted agents. The UM-SCC panel culture is well-established in DMEM with 10% FBS and 1% NEAA, matching standard UM-SCC culture conditions across the collection. As with all UM-SCC lines, STR authentication and TP53 mutation status confirmation are recommended prior to experiments.

Tissue
Head and neck
Disease
Head and neck squamous cell carcinoma (HNSCC)
Metastatic site
Primary tumor site (head and neck)
Applications
HNSCC research; radiation sensitivity; cisplatin/5-FU/cetuximab sensitivity; EGFR pathway analysis; TP53 functional studies; targeted therapy evaluation

02Classification

Organism
Human
Sex
Unspecified
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; wildtype HNSCC cell line
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 24 to 48 hours

04Identifiers

Citation
UM-SCC-129 (Cytion catalog number 305727)
NCBI TaxID
9606
Cellosaurus
Not assigned

05Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS and 1% NEAA
Dissociation reagent
Accutase
Subculturing
Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
Split ratio
1 to 5
Seeding density
1 to 3 × 104 cells/cm2
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

06Quality control and cryopreservation

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
Age unspecified
Ethnicity
Ethnicity unspecified